HRA Pharma Investigational Site 1013 — New York, New York

HRA Pharma Investigational Site 1013 is a clinical research site located in New York, New York, United States 10034.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

HRA Pharma Investigational Site 1013 has participated in 1 clinical trials.

Therapeutic areas: Contraception.

Sponsors: HRA Pharma.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for HRA Pharma Investigational Site 1013?

HRA Pharma Investigational Site 1013 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has HRA Pharma Investigational Site 1013 conducted?

HRA Pharma Investigational Site 1013 has 1 clinical trials on record. Their work covers Contraception.

Is HRA Pharma Investigational Site 1013 accredited by Crixeo Health?

HRA Pharma Investigational Site 1013 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about HRA Pharma Investigational Site 1013?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.